1/87
Looks like no tags are added yet.
Nervous System Physiology- Overview: CNS
Brain
Spinal Cord
Nervous System Physiology-Overview: Autonomic Nervous System
Automatic, uncontrolled processes
Sympathetic vs Parasympathetic
Neuropharmacologic Drug:
Works by influencing receptor activity on target cells
Autonomic Nervous System: Sympathetic (Adrenergic)
Fight or Flight
Responds to outside stimuli
Receptors respond to catecholamines:
Epinephrine
Norepinephrine
Dopamine
Autonomic Nervous System: Parasympathetic (Cholinergic)
Rest and Digest
Run in the background
Receptors respond to:
Acetylcholine
Cholinergic Receptors:
Respond to Neurotransmitter Acetlycholine
Cholinergic Receptors: Nicotinic N & M
Nicotinic N = Neuron = on postganglionic neuron and adrenal medulla
Nicotinic M = Muscle = on skeletal muscle
Cholinergic Receptors: Muscarinic
On organs regulated by parasympathetic system including smooth muscle and glands
• M1 = CNS & Salivary glands
• M2 = Heart
• M3 = Eyes, salivary glands, GI, urinary bladder, blood vessels
• M4 = CNS (motor control/cognition)
• M5 = CNS (dopaminergic areas of brain)
Sympathetic (Adrenergic Receptors)
Adrenergic = Adrenals, Adrenaline and Epinephrine
• Dopamine
• Alpha 1
• Alpha 2
• Beta 1
• Beta 2
Adrenergic System: Fight or Flight (Alpha 1 Receptors) produce:
Mydriasis (Pupil Dilation)
Constriction of arterioles supplying skin, viscera, and mucous membranes
Venous constriction to increase venous return
Contraction of prostatic capsule and bladder trigone and sphincter
Uterine contraction and ejaculation
Adrenergic System: Fight or Flight (Alpha 2 Receptors)
(Inhibitory receptor to stop response)
• Inhibits neurotransmitter release at presynaptic nerve terminals
Adrenergic System: Fight or Flight (Beta 1 Receptors)
(Mnemonic: You only have ONE HEART)
• Increased rate, conduction, and force of contraction on heart
• Releases renin from kidney
Adrenergic System: Fight or Flight (Beta 2 Receptors)
(Mnemonic: You have TWO LUNGS)
• Dilation of arterioles supplying heart, lungs, and skeletal muscle
• Dilation of bronchi
• Enhanced glycogenolysis in the liver
• Uterine Relaxation
Adrenergic System: Fight or Flight (Dopamine Receptors)
Dilation of Kidney Vasculature
Adrenergic Effects: Alpha Receptors
Alpha Receptor Result in:
• Better vision (more light gets in)
• Blood redirected to essential functions
• Increased Blood Pressure via improved venous return
• Delayed bladder emptying
• Uterine Contraction and Ejaculation
Adrenergic Effects: Beta Receptors
Increased cardiac output via increased heart rate and activation of RAAS
• Increased blood flow to essential organs (heart, lungs, skeletal muscle)
• Improved oxygenation through bronchodilation
• Ready supply of fuel (glucose) via glycogenolysis
• Improved renal perfusion
Preterm Labor: Adrenergic Effects
Beta 2 causes uterine relaxation, and Beta 2 Agonists have been used in the past to arrest pre-term labor.
New evidence shows babies may have higher risk for asthma later in life
Cholinergic Drug Categories: Muscarinic Agonist
Bethanechol
Pilocarpine
Cholinergic Drug Categories: Muscarinic Antagonists
Atropine
Oxybutynin
Cholinergic Drug Categories: Cholinesterase Inhibitors
Neostigmine
Physostigmine
Edrophonium
Muscarinic Agonists: AKA?
“Parasympathomimetics” - mimics effects of parasympathetic nervous system
Muscarinic agonists bind to muscarinic receptors and cause receptor activation
Muscarinic Agonists: NTN
Bethanechol (Urecholine, Duvoid)
Muscarinic Agonists: Bethanechol (Urecholine, Duvoid) MOA
Stimulates muscarinic receptors to allow bladder to empty
Indication: Urinary Retention in post-op or postpartum PTs
Muscarinic Agonists: Bethanechol (Urecholine, Duvoid) Pharmacokinetics
Given PO, Polar (so crosses membranes poorly)
Not well absorbed. Other unknown PKs.
Muscarinic Agonists: Bethanechol (Urecholine, Duvoid) AE
Hypotension & Bradycardia
Excessive salivation, GI motility & diarrhea
Bronchoconstriction (contraindicated in asthma)
Muscarinic Agonists: Pilocarpine
Binds to smooth muscle and causes smooth muscle contraction
Indications:
Glaucoma: binds to smooth muscle cells in the eye (iris ciliary) to cause constriction to promote aqueous humor flow
Xerostomia: promotes salivation by stimulating salivary secretion
Muscarinic Agonists: Pilocarpine Pharmacokinetics
Administered via:
Solution (eye drops), gel for (glaucoma)
Tablets for (xerostomia)
Muscarinic Agonists: Pilocarpine Pharmacokinetics Implications
Avoid high fat foods with oral admin
no adequate studies in children or those lactating – unknown Pks
Muscarinic Agonists: Pilocarpine Pharmacokinetics AE
GI motility
N/V/D
Increased sweating
Muscarinic Antagonist: Atropine
Blocks Muscarinic Receptors yielding anticholinergic effects
Indications:
Dries up secretions (useful in surgery)
Increases HR (drug of choice for bradycardia)
Pupil dilation (useful for eye exams)
Muscarinic agonist poisoning (poison mushrooms)
Muscarinic Antagonist: Atropine AE
Blurred vision, increased IOP
Tachycardia
Urinary retention, constipation
Xerostomia (dry mouth)
anhidrosis (absence of sweating)
Treatment for OAB BEFORE Pharmacologic interventions
Nonpharmacologic interventions first:
• Bladder training (timed voiding and fluid intake)
• Kegel exercises
• Avoid bladder irritants such as caffeine
Muscarinic Antagonist For OAB: Pharmacology Therapy NTN
Oxybutynin (Ditropan XL)
Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL)
Block ACh at M3 receptors
• Relax bladder detrusor and contract trigone and sphincter
Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL) AE
Anticholinergic symptoms
• Xerostomia (dry mouth)
• Constipation
• Blurred vision
Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL) Pharmacokinetics
Lipid-soluble - can enter the CNS and cross membranes
Short half-life - Multiple Doses/Day
• Significant first-pass metabolism
Muscarinic Antagonist For OAB: Oxybutynin (Ditropan XL) Administration
• Long-acting formulations available (equal efficacy with reduced side effects)
• Extended-release tablets
• Transdermal patch
Cholinesterase Inhibitors: Main Indicator
Myasthenia Gravis (grave muscle weakness)
Autoimmune disorder that destroys nicotinic (M) receptors on skeletal muscle, causing muscle weakness
Also (Reversal of nondepoloarizing neuromuscular blockade)
Cholinesterase Inhibitors: MOA
Inhibits cholinesterase preventing breakdown of ACh
Increases bioavailability of Ach
Ensures as many Nicotinic M receptors are activated as possible
Cholinesterase Inhibitors: NTN
Neostigmine/Physostigmine
Binds to cholinesterase but takes a LONG time to breakdown
Cholinesterase Inhibitors: Neostigmine/Physostigmine Pharmacokinetics
IM, IV, SC, poor oral absorption
Cholinesterase Inhibitors: Neostigmine/Physostigmine Therapeutic vs Toxic Dose
Therapeutic doses =
CNS excitation and skeletal muscle contraction ( ACh)
Toxic doses =
CNS Depression and skeletal muscle weakness
Cholinergic Crisis: SLUD
Salivation
Lacrimaton
Urination
Defacation
Cholinergic Crisis: SLUDGE AND THE KILLER Bs
• Salivation
• Lacrimation
• Urination
• Diaphoresis/Diarrhea
• Gastrointestinal cramping
• Emesis
• Bradycardia
• Bronchospasm
• Bronchorrhea
Cholinergic Crisis vs Myasthenia Crisis
Admin. Edrophonium
◦ Cholinesterase inhibitor
◦ If Ach levels and symptoms are alleviated = Myasthenic
◦ If Symptoms are intensified= Cholinergic
◦ Can be life threatening!
◦ MUST have oxygen and atropine available immediately to treat
Adrenergic Agonists Categories: Catecholamine Adrenergic Agonists
Epinephrine,
Norepinephrine
Dopamine
Adrenergic Agonists Categories: Noncatecholamine Adrenergic Agonists
Albuterol
Phenylephrine
Adrenergic Agonists: Catecholamines
Polar molecules
• Cannot pass membranes
• Cannot penetrate blood-brain barrier
Metabolism
Metabolized by enzymes Monoamine Oxidase (MAO) and COMT in intestine and liver
Not bioavailable following oral administration due to first-pass effect, must be given parenterally (IV, IM, SC)
• VERY short half-life; needs continuous IV infusion to maintain MEC
Adrenergic Agonists: Catecholamines Administration
Given parenterally (IV, IM, SC)
IV= systemic effects
Topical/local injection = local effects
Adrenergic Agonists: Epinephrine
Nonselective adrenergic agonist:
• Stimulates all alpha and beta receptors
Adrenergic Agonists: Epinephrine Therapeutic Uses
Anaphylactic shock - drug of choice EPI-PEN - IM Admin.
• Cardiopulmonary arrest
• Ventricular fibrillation
• Asthma
• Local vasoconstriction
• Adjunct for local anesthesia
Adrenergic Agonists: Epinephrine AE
Related to stimulation of all adrenergic receptors
• Hypertensive Crisis
• Dysrhythmias
• Angina
• Necrosis after extravasation
• Hyperglycemia
Adrenergic Agonists: Epinephrine Pharmacokinetics
Significant first-pass effect: must be given parenterally
Short half-life:
Anaphylaxis MUST have follow-up treatment with monitoring, steroids, antihistamines, etc. as can recur after Epipen
Adrenergic Agonists: Epinephrine Drug Interactions
MAO Inhibitors (MAOI’s)
Prolong/intensify effects of epinephrine
Tricyclic Antidepressants
Prolong/intensify effects
General anesthetics
Tachy dysrhythmias
Alpha and Beta Blockers
Counteract each other’s effects
Adrenergic Agonists: Norepinephrine (Levophed)
Norepinephrine (Levophed)
• Same as epinephrine but does not stimulate Beta-2
• No bronchodilation
• No hyperglycemia
Adrenergic Agonists: Norepinephrine (Levophed) Indications
Hypotension = “pressor” = vasopressor: peripheral vasoconstriction
• Increases blood pressure by increasing peripheral vascular resistance
Adrenergic Agonists: Dopamine (Inotropin)
Dopamine (Inotropin)
• Catecholamine and precursor to NE
• Stimulates dopamine receptors and dose-dependent beta-1 and alpha-1 stimulation
Adrenergic Agonists: Dopamine (Inotropin) Indication
Vasopressor used in treating shock
Adrenergic Agonists: Dopamine (Inotropin) Administration
IV administration only in acute care settings
• Invasive monitoring, pump
• Correct hypovolemia first
• Weight based dosing
Nonacatecholamine: Adrenergic Agonist Pharmacokinetics
Nonpolar:
Can pass through the BBB
Metabolism
Slowly metabolized by MAO
Given PO
Nonacatecholamine: Selective Adrenergic Agonist: Albuterol (ProAir, Ventolin)
Selective Beta-2 Agonist
Also Beta-1 Agonist at high doses
Common side-effect: tachycardia
Nonacatecholamine: Selective Adrenergic Agonist: Phenleyphrine
Alpha-1 Agonist:
Potent vasoCONSTRICTOR
Indications for Use:
Hypotension
Shock
Adjunct for local anesthesia
Nasal decongestant (Sudafed PE)
Pupil Dilation (Mydriasis)
Adrenergic ANTAGONIST Alpha 1: Blockers NTK
Prazosin
Tamulosin
Alpha Blockers MOA
Blocks Alpha-1 Receptors on Blood Vessles
Blocks Alpha1 receptors on Bladder and Prostate
Alpha Blockers: Therapeutic Uses
Essential Hypertension
BPH
Alpha Blockers: Prazosin (Minipress) Indications
Hypertension and Benign Prostatic Hyperplasia (BPH)
Alpha Blockers: Prazosin (Minipress) Adverse Effects
Orthostatic Hypotension
Reflex Tachycardia
Nasal Congestion
Inhibition of Ejaculation
Alpha Blockers: Tamsulosin (Flomax) MOA
Selective Alpha-1 Blockade
Only blocks alpha receptops in smooth muscle of bladder, prostate, and urethra
Indications: BPH ONLY
Adrenergic ANTAGONIST: Beta Blockers NTK
Propanolol
Metoprolol
Timolol
Beta Blockers:
Blocks Beta-1 and/or Beta-2 Receptors:
Therapeutic Uses:
Hypertention
Cardiac Dysrythmias
Hyperthyroidism
Migraine
Performance Anxiety: Stage Freight and Test Anxiety
Beta Blockers: Adverse Effects
Bracycardia
Hypotension
Bronchoconstriction
Mask symptoms of hypoglycemia
Beta Blockers: Propanaolol (Inderal) Non-Selective
Beta-1 and Beta-2 Blockade
Beta 1 Blockade: Therapeutic Effect
Reduced Heart Rate, Force of Contraction
Beta 2 Blockade: Adverse Effects
Bronchoconstriction
Inhibition of glycogenolysis
Blocks effects of epineprhine on airways
Beta Blockers: Propanaolol (Inderal) Non-Selective CAUTION IN PTs
COPD/Asthma
Diabetes
History of Severe Allergies and/or Anaphylaxis
Beta Blockers: Propanaolol (Inderal) Pharmacodynamics
Lipid Soluble: easily crosses membrane
BBB and Placenta
Neonate exposure: monitor for days due to Beta-1 and Beta-2 Blockade
Extensive First Pass Effect:
Only 30% bio-available with oral administration
Beta Blockers: Metoprolol (Lopressor)
Cardioselective (Beta-1 only) at normal doses
Similar PK, Side effect, and drug interactions as Propanolol except:
Preferred in asthma and diabetes due to selective action
Adrenergic ANTAGONIST: Alpha AND Beta Blockers:
Carvedilol
Labetalol
Beta Blockers: Carvedilol (Coreg) and Labetalol (Normodyne)
Blocks Beta 1 and Beta 2 and Selective Alpha 1
Alpha blocking cause peripheral vasoDILATION
Beta Blocking prevents reflex tachycardia and renin release
Same concerns as other alpha/beta blockers
Risk of hypotension/bradychardia
Use in caution with Asthma and Diabetes
Adrenergic ANTAGONIST: Central Acting Alpha2 Agonist: NTK
Clonidine
Methyldopa
Central Acting Alpha2 Agonist: MOA
Activated Alpha-2 receptors send a message to reduce norepinephrine synthesis
Less catecholamine release = VasoDILATION
Indicated for HTN
Tendency to cause excessive sedation, dizziness, orthostatic hypotension, NA ad H2O Retention
Central Acting Alpha2 Agonist: Clonidine (Catapres)
Inhibits sympathetic nervous system response and reduces sympathetic outflow from the CNS
Decrease HR, BP, vasoconstriction and vascular resistance
Severe rebound HTN if discontinued
Causes Xerostomia (dry mouth)
give hard candy
Central Acting Alpha2 Agonist: Methyldopa (Aldomet)
Converts to methylnorepinephrine and displaces norepinephrine from storage sites
Drug choice for pregnant women with HTN
Demonstrates improved outcomes without fetal harm
Hepatotoxic: Check LFTS before and during treatment
A patient receives a medication that results in the activation of the acetylcholine
receptors of the heart. The nurse should assess the patient for which intended
effect?
A. Decreased heart rate
B. Dysrhythmia suppression
C. Increased heart rate
D. Improved contractilit
A. Decreased heart rate
The nurse instructs a patient with myasthenia gravis who is taking
neostigmine [Prostigmin]. Which statement, if made by the patient to the
nurse, indicates an understanding of the instructions?
A. “The antidote for this medication is norepinephrine.”
B. “An extra dose should be taken if paralysis occurs.”
C. “A medical alert bracelet should be worn at all times.”
D. “The medication will be prescribed for 2 to 3 months
C. “A medical alert bracelet should be worn at all times.”
The nurse administers a medication to a patient that stimulates the function of the
parasympathetic nervous system. The nurse should assess the patient for which
intended effect?
A. Reduced esophageal motility
B. Improved bladder emptying
C. Dilation of the pupils
D. Decreased gastric secretion
B. Improved bladder emptying
A patient is prescribed bethanechol [Urecholine] for urinary retention. If the
patient exhibits signs of an overdose, such as increased salivation and
sweating, bradycardia, or hypotension, which medication should the nurse
administer?
A. Acetylcholine [Miochol-E]
B. Cevimeline [Evoxac]
C. Oxybutynin [Ditropan]
D. Atropine [AtroPen]
D. Atropine [AtroPen]
The nurse cares for a patient with myasthenia gravis. Before administering
pyridostigmine [Mestinon], it is most important for the nurse to take which
action?
A. Assess the patient’s ability to swallow a sip of water.
B. Cleanse the patient’s skin before applying the transdermal patch.
C. Ask whether the patient has an allergy to aspirin.
D. Give the patient food or milk to prevent stomach upset
A. Assess the patient’s ability to swallow a sip of water.
The nurse is caring for a patient who was foraging and consumed a handful of
mushrooms. The patient is now having difficulty breathing, bradycardia, and
severe hypotension. Based on the presentation, which intervention should the
nurse expect to take immediately?
A. Prepare the patient for the cath lab
B. Administer Atropine
C. Call the family members to try to identify the mushrooms
D. Alert the blood bank of the patient’s arriva
B. Administer Atropine
A patient who has myasthenia gravis reports extreme muscle weakness.
Which of the following medications should the nurse prepare to administer to
distinguish myasthenic crisis from cholinergic crisis?
A. Echothiophate [Phospholine iodide]
B. Edrophonium [Tensilon]
C. Atropine [AtroPen]
D. Ambenonium [Mytelase
B. Edrophonium [Tensilon]